EPR Properties vs Novartis AG — how do they compare? EPR Properties trades at $60 (market cap $4.58B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 64.5× EPR Properties's market cap, and EPR Properties pays the higher dividend (6.22%). Which is the better fit depends on your goals.
| EPR | NVS | |
|---|---|---|
Market Cap | $4.58B | $295.37B |
Sector | Real Estate | Health |
52-Week High | $64.32 | $168.62 |
52-Week Low | $48.71 | $119.31 |
Enterprise Value | $8.09B | $336.69B |
Dividend Yield | 6.22% | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →